Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2021

The activity for stock options under the Company’s stock plans for the six months ended June 30, 2021 is as follows:

							Remaining
							weighted-
					Weighted-		average		Per share
					average		contractual		average
				Price per	exercise		terms		intrinsic
	Options			share	price		(in years)		value
Outstanding as of December 31, 2020		955,479		$0.75-$83.30	$	35.49		1.85	$	11.81
Exercised		(377,301	)	0.75-46.66		26.39
Outstanding as of June 30, 2021		578,178		0.81-83.30		41.43		1.73		25.77
Vested and exercisable as of June 30, 2021		578,178		0.81-83.30		41.43		1.73		25.77
Vested and expected to vest as of June 30, 2021		578,178		$0.81-$83.30	$	41.43		1.73	$	25.77

Summary of Restricted Stock Activity

Stock Awards activity for the six months ended June 30, 2021 is summarized below:

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock units	Time-based			time-based			Total			per share
Unvested restricted stock units as of December 31, 2020		245,462			88,458			333,920		$	49.29
Granted		214,950			88,902			303,852			55.18
Vested		(83,458	)		—			(83,458	)		49.99
Forfeited/canceled		(62,516	)		(69,276	)		(131,792	)		45.59
Unvested restricted stock units as of June 30, 2021 ⁽¹⁾		314,438			108,084			422,522		$	54.42
Unvested and expected to vest restricted stock units outstanding as of June 30, 2021								366,549		$	54.43

										Weighted-
										average
										grant
				Performance						date fair
				and						value
Restricted stock awards	Time-based			time-based			Total			per share
Unvested restricted stock awards outstanding as of December 31, 2020		42,076			33,355			75,431		$	93.96
Vested		(10,635	)		—			(10,635	)		92.84
Forfeited/canceled		(13,945	)		(27,399	)		(41,344	)		100.89
Unvested restricted stock awards outstanding as of June 30, 2021 ⁽¹⁾		17,496			5,956			23,452		$	84.10
Unvested and expected to vest restricted stock awards outstanding as of June 30, 2021								22,585		$	86.72

(1)	Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three and six months ended June 30, 2021 and June 30, 2020, was as follows:

	Three months ended				Six months ended
	June 30,				June 30,
	2021		2020		2021		2020
Stock-based compensation expense by type of award:
Stock option plan awards	$	—	$	184	$	—	$	709
Restricted stock units and restricted stock awards		3,053		892		5,383		2,975
Employee stock purchase plan		186		201		372		377
Total stock-based compensation expense	$	3,239	$	1,277	$	5,755	$	4,061

For the three and six months ended June 30, 2021 and June 30, 2020, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

	Three months ended				Six months ended
	June 30,				June 30,
	2021		2020		2021		2020
Cost of revenue	$	319	$	97	$	557	$	326
Research and development		382		173		680		493
Sales and marketing		668		459		1,280		1,071
General and administrative		1,870		548		3,238		2,171
Total stock-based compensation expense	$	3,239	$	1,277	$	5,755	$	4,061